数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

股本结构

单位:万股
公告日期 2021-11-09 2021-11-09 2021-08-09 2021-08-09 2021-05-10 2021-05-10
证券总股本 14681.27 14680.80 13678.80 13660.60 13547.04 13539.90
普通股本 14681.27 14680.80 13678.80 13660.60 13547.04 13539.90
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2021-11-05 2021-09-30 2021-08-06 2021-06-30 2021-05-07 2021-03-31
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2021-11-09 14681.27 未披露 定期报告 2021-11-05
2021-11-09 14680.80 未披露
更多>>
From June 30, 2021 to September 30, 2021 Upon vesting of restricted stock awards portion of settlement obligation For exercise of stock options
2021-09-30
2021-08-09 13678.80 未披露 定期报告 2021-08-06
2021-08-09 13660.60 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of Common Stock: In Ariix business combination Upon vesting of restricted stock awards For exercise of stock options Reclassification of Redeemable Common Stock
2021-06-30
2021-05-10 13547.04 未披露 定期报告 2021-05-07
2021-05-10 13539.90 未披露
更多>>
From December 31, 2020 to March 31, 2021 Issuance of Common Stock: In Ariix business combination Private placement of Common Stock, net of issuance costs Vesting of restricted stock awards Exercise of stock options Reclassification of Redeemable Common Stock
2021-03-31
2021-03-29 13538.74 未披露 定期报告 2021-03-24
2021-03-18 13538.99 未披露 定期报告 2021-03-15
2021-03-18 13538.99 未披露 定期报告 2021-03-12
2021-02-12 12052.89 未披露 定期报告 2021-02-09
2021-02-08 12052.05 未披露 定期报告 2021-02-04
2021-02-01 11986.38 未披露 定期报告 2021-01-28
2021-03-18 9914.60 未披露
更多>>
From December 31, 2019 to December 31, 2020 Issuance of Common Stock: In ATM public offering, net of offering costs In exchange for note receivable For exercise of stock options Upon vesting of restricted stock awards Purchase and retirement of common stock
2020-12-31
2020-11-09 9852.14 未披露 定期报告 2020-11-06
2020-11-09 9849.00 未披露
更多>>
From December 31, 2019 to September 30, 2020 Issuance of Common Stock: ATM public offering, net of offering costs In exchange for note receivable Exercise of stock options Vesting of restricted stock awards
2020-09-30
2020-08-10 9772.01 未披露 定期报告 2020-08-06
2020-08-10 9844.20 未披露
更多>>
From December 31, 2019 to June 30, 2020 Issuance of Common Stock: ATM public offering, net of offering costs Exercise of stock options Vesting of restricted stock awards
2020-06-30
2020-05-11 9259.24 未披露 定期报告 2020-05-07
2020-04-28 9087.25 未披露 定期报告 2020-04-24
2020-05-11 8724.50 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issuance of Common Stock for: ATM public offering, net of offering costs Exercise of stock options Vesting of restricted stock awards
2020-03-31
2020-03-16 8543.70 未披露 定期报告 2020-03-10
2020-03-16 8187.30 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of Common Stock: ATM public offering, net of offering costs Grant of restricted stock awards Vesting of restricted stock awards Business combination with BWR Employee services Acquisition of patents Exercise of stock options
2019-12-31
2019-11-14 7839.40 未披露 定期报告 2019-11-11
2019-11-14 7827.40 未披露
更多>>
From June 30, 2019 to September 30, 2019 Issuance of Common Stock for: Exercise of stock options Grant of restricted stock awards Business combination with BWR ATM public offering, net of offering costs Employee services
2019-09-30
2019-08-08 7816.60 未披露 定期报告 2019-08-05
2019-08-08 7762.40 未披露
更多>>
From December 31, 2018 to June 30, 2019 Issuance of Common Stock for: Exercise of stock options Grant of restricted stock awards ATM public offering, net of offering costs Employee services
2019-06-30
2019-04-16 7539.27 4.38 定期报告 2019-04-12
2019-04-05 7535.77 4.38 定期报告 2019-04-04
2019-05-09 7539.30 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of Common Stock for: Exercise of stock options Grant of restricted stock awards
2019-03-31
2019-04-01 7535.77 未披露 定期报告 2019-03-29
2019-04-01 7506.70 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of Common Stock for: Conversion of Series B Preferred Stock Conversion of Series B promissory notes Public offerings, net of offering costs Debt issuance costs Transaction costs in business combination Cashless exercise of stock options and warrants Grant of restricted stock awards, net of forfeitures Common Stock exchanged for Series C Preferred Stock Series C Preferred Stock converted to Common Stock Common Stock issued in business combination with Morinda
2018-12-31
2018-12-03 7283.59 未披露 定期报告 2018-11-29
2018-11-14 7283.59 未披露 定期报告 2018-11-14
2018-11-14 4951.41 0.69 定期报告 2018-09-30
2018-09-17 4939.85 未披露 定期报告 2018-09-10
2018-08-14 4010.92 未披露 定期报告 2018-08-06
2018-08-07 3993.46 未披露 定期报告 2018-07-30
2018-08-14 3992.58 未披露 定期报告 2018-06-30
2018-05-15 3920.79 未披露 定期报告 2018-05-08
2018-04-17 3893.36 未披露 定期报告 2018-04-12
2018-05-15 3664.79 未披露 定期报告 2018-03-31
2018-04-17 3517.14 16.92
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock in connection with public offering Issuance of common stock in connection with the acquisition of Maverick Brands, LLC Issuance of common stock in connection with the acquisition of Marley Beverages, LLC Issuance of common stock in connection with the acquisition of Premier Micronutrient Corporation Issuance of common stock in connection with services provided Restricted stock awards issued to employees Recession of Series A Preferred Shares Conversion of Series B Preferred Stock Exercise of warrants
2017-12-31
2017-11-14 3461.53 未披露 定期报告 2017-11-13
2017-11-14 3461.03 未披露 定期报告 2017-09-30
2017-08-15 3433.05 未披露 定期报告 2017-06-30
2017-05-16 3130.71 53.48 定期报告 2017-03-31
2017-03-31 2770.09 未披露 定期报告 2017-03-24
2017-02-14 2274.73 49.73
更多>>
1.The number of shares of our common stock that will be outstanding immediately after this offering is based on 22,000,106 shares of our common stock outstanding as of February 7, 2017
2017-02-14
2017-03-31 2190.01 53.48
更多>>
from December 31, 2015 to September 30, 2016 Common stock issued in Xing acquisition Stock-based compensation Exercise of warrant
2016-09-30
From June 30, 2021 to September 30, 2021 Upon vesting of restricted stock awards portion of settlement obligation For exercise of stock options
From March 31, 2021 to June 30, 2021 Issuance of Common Stock: In Ariix business combination Upon vesting of restricted stock awards For exercise of stock options Reclassification of Redeemable Common Stock
From December 31, 2020 to March 31, 2021 Issuance of Common Stock: In Ariix business combination Private placement of Common Stock, net of issuance costs Vesting of restricted stock awards Exercise of stock options Reclassification of Redeemable Common Stock
From December 31, 2019 to December 31, 2020 Issuance of Common Stock: In ATM public offering, net of offering costs In exchange for note receivable For exercise of stock options Upon vesting of restricted stock awards Purchase and retirement of common stock
From December 31, 2019 to September 30, 2020 Issuance of Common Stock: ATM public offering, net of offering costs In exchange for note receivable Exercise of stock options Vesting of restricted stock awards
From December 31, 2019 to June 30, 2020 Issuance of Common Stock: ATM public offering, net of offering costs Exercise of stock options Vesting of restricted stock awards
From December 31, 2019 to March 31, 2020 Issuance of Common Stock for: ATM public offering, net of offering costs Exercise of stock options Vesting of restricted stock awards
from December 31, 2018 to December 31, 2019 Issuance of Common Stock: ATM public offering, net of offering costs Grant of restricted stock awards Vesting of restricted stock awards Business combination with BWR Employee services Acquisition of patents Exercise of stock options
From June 30, 2019 to September 30, 2019 Issuance of Common Stock for: Exercise of stock options Grant of restricted stock awards Business combination with BWR ATM public offering, net of offering costs Employee services
From December 31, 2018 to June 30, 2019 Issuance of Common Stock for: Exercise of stock options Grant of restricted stock awards ATM public offering, net of offering costs Employee services
from December 31, 2018 to March 31, 2019 Issuance of Common Stock for: Exercise of stock options Grant of restricted stock awards
from December 31, 2017 to December 31, 2018 Issuance of Common Stock for: Conversion of Series B Preferred Stock Conversion of Series B promissory notes Public offerings, net of offering costs Debt issuance costs Transaction costs in business combination Cashless exercise of stock options and warrants Grant of restricted stock awards, net of forfeitures Common Stock exchanged for Series C Preferred Stock Series C Preferred Stock converted to Common Stock Common Stock issued in business combination with Morinda
from December 31, 2016 to December 31, 2017 Issuance of common stock in connection with public offering Issuance of common stock in connection with the acquisition of Maverick Brands, LLC Issuance of common stock in connection with the acquisition of Marley Beverages, LLC Issuance of common stock in connection with the acquisition of Premier Micronutrient Corporation Issuance of common stock in connection with services provided Restricted stock awards issued to employees Recession of Series A Preferred Shares Conversion of Series B Preferred Stock Exercise of warrants
1.The number of shares of our common stock that will be outstanding immediately after this offering is based on 22,000,106 shares of our common stock outstanding as of February 7, 2017
from December 31, 2015 to September 30, 2016 Common stock issued in Xing acquisition Stock-based compensation Exercise of warrant